Cargando…
Unanticipated efficacy of SARS-CoV-2 vaccination in older adults
The rapidity with which vaccines against COVID-19 have been developed and tested is unprecedented. As classically the case with randomized clinical trials, many studies excluded older adults. However, given the early realisation that senior citizens were most highly susceptible to COVID, older indiv...
Autores principales: | Pawelec, Graham, McElhaney, Janet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886644/ https://www.ncbi.nlm.nih.gov/pubmed/33596958 http://dx.doi.org/10.1186/s12979-021-00219-y |
Ejemplares similares
-
Vaccines for Improved Cellular Immunity to Influenza
por: Pawelec, Graham, et al.
Publicado: (2018) -
Improving seasonal influenza vaccination for older adults
por: Pawelec, Graham, et al.
Publicado: (2021) -
Validation of the effectiveness of SARS-CoV-2 vaccines in older adults in “real-world” settings
por: Weng, Nan-ping, et al.
Publicado: (2021) -
Recent advances in influenza vaccines
por: Pawelec, Graham, et al.
Publicado: (2020) -
Considering Frailty in SARS-CoV-2 Vaccine Development: How Geriatricians Can Assist
por: Andrew, Melissa K, et al.
Publicado: (2021)